Finance

Beta
Lists
AIDX:NASDAQ
20/20 Biolabs Inc
$0.61
-0.20%
(-0.0012) 1D
$0.60
-1.36% (-0.0083)
After hours
Closed: Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIDX...
Open
$0.64
High
$0.65
Low
$0.59
Mkt. cap
7.45M
Avg. vol.
1.55M
Volume
593.92K
52-wk high
$50.00
52-wk low
$0.52
EPS
-$0.94
No. of employees
9
Open
$0.64
High
$0.65
Low
$0.59
Mkt. cap
7.45M
Avg. vol.
1.55M
Volume
593.92K
52-wk high
$50.00
52-wk low
$0.52
EPS
-$0.94
No. of employees
9
News stories
From sources across the web
About 20/20 Biolabs Inc
CEO-
Employees9
Founded2000
HeadquartersRockville, Maryland, United States
SectorMedical device
Website2020biolabs.com
Analyst ratings
Based on 1 analyst giving stock ratings to AIDX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for AIDX in the last 3 months
Highest
Current $0.61
$5.00 (+721.96%)
Average
$5.00 (+721.96%)
Lowest
$5.00 (+721.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+722%
05/21/2026
Brian Kinstlinger
Alliance Global Partners
Buy
Maintained
CA$2.00
+228.8%
05/08/2026
Justin Keywood
Stifel Nicolaus
Buy
Maintained
CA$2.50
+311%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
553.82K
417.98K
538.27K
353.38K
Cost of goods sold
388.02K
272.91K
407.86K
290.49K
Cost of revenue
388.02K
272.91K
407.86K
290.49K
Research and development expenses
136.83K
131.06K
130.55K
153.48K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
801.14K
814.18K
912.71K
1.35M
Operating expense
937.98K
945.24K
1.04M
1.51M
Total operating expenses
1.33M
1.22M
1.45M
1.80M
Operating income
-772.18K
-800.17K
-912.85K
-1.44M
Other non operating income
-115.00
-
-273.03K
-471.12K
EBT including unusual items
-764.58K
-825.54K
-1.31M
-2.17M
EBT excluding unusual items
-764.58K
-825.54K
-1.31M
-2.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-764.58K
-825.54K
-1.31M
-2.17M
Net profit margin
-138.06%
-197.51%
-242.96%
-615.45%
Earnings per share
-
-
-
-
Interest and investment income
8.46K
4.18K
3.09K
6.65K
Interest expense
-740.00
-29.55K
-124.98K
-267.01K
Net interest expenses
7.72K
-25.37K
-121.90K
-260.36K
Depreciation and amortization charges
-
-
-
-
EBITDA
-748.73K
-779.11K
-892.71K
-1.43M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer